Antipodes Partners’s Ventas VTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.6M Sell
592,870
-199,508
-25% -$17M 0.96% 41
2026
Q1
$64.8M Sell
792,378
-64,594
-8% -$5.29M 1.25% 36
2025
Q4
$66.3M Sell
856,972
-243,423
-22% -$18.4M 1.39% 32
2025
Q3
$77M Sell
1,100,395
-435,646
-28% -$29.3M 1.73% 26
2025
Q2
$97M Buy
1,536,041
+69,581
+5% +$4.54M 3.01% 15
2025
Q1
$101M Sell
1,466,460
-17,126
-1% -$1.09M 3.16% 13
2024
Q4
$87.4M Buy
1,483,586
+33,670
+2% +$2.12M 3.04% 13
2024
Q3
$93M Buy
1,449,916
+15,718
+1% +$918K 3.22% 10
2024
Q2
$73.5M Buy
+1,434,198
New +$67.2M 2.67% 18

Other funds holding VTR

Antipodes Partners's VTR Position: Q2 2026 in Review

Antipodes Partners reduced its Ventas (VTR) stake by 25% in Q2 2026, selling an estimated $17M and leaving 592,870 shares worth $52.6M. The position accounts for 0.96% of the portfolio, ranked #41.

Antipodes Partners first reported a position in VTR in Q2 2024 and has held it in 9 quarters since. The position peaked at $101M in Q1 2025. 551 funds tracked by Wall St. Rank hold VTR as of Q2 2026.

  • Antipodes Partners held 592,870 shares of Ventas worth $52.6M as of Q2 2026.
  • Antipodes Partners sold 199,508 Ventas shares in Q2 2026, an estimated $17M.
  • Ventas made up 0.96% of Antipodes Partners's portfolio in Q2 2026, its #41 holding.
  • Antipodes Partners first reported a position in Ventas in Q2 2024 and has held it in 9 quarters since.
  • Antipodes Partners's Ventas position peaked at $101M in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Ventas as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.